BAILARD, INC. Q1 2023 Filing

Filed May 8, 2023

Portfolio Value

$2.8B

Holdings

710

Report Date

Q1 2023

Filing Type

13F-HR

All Holdings (710 positions)

#	Stock	Shares	Value	% Portfolio	Type
701	CMRXEURCHIMERIX INC	33,600	$42K	0.00%
702	PAYSPAYSIGN INC	11,400	$41K	0.00%
703	—AGILETHOUGHT INC	13,000	$41K	0.00%
704	GEVOGEVO INC	26,300	$41K	0.00%
705	KRON1USDKRONOS BIO INC	27,700	$40K	0.00%
706	BOLT1EURBOLT BIOTHERAPEUTICS INC	28,500	$40K	0.00%
707	TRVITREVI THERAPEUTICS INC	21,200	$39K	0.00%
708	OVIDOVID THERAPEUTICS INC	12,600	$33K	0.00%
709	RYIVIRACTA THERAPEUTICS INC	19,900	$32K	0.00%
710	—TALARIS THERAPEUTICS INC	14,773	$28K	0.00%

PreviousPage 8 of 8